Table 1.
Challenges | Implemented or proposed solutions |
---|---|
Ensuring drug supply across a global network of sites | • Request for waiving of relabelling requirements • Centralised drug management and distribution through two drug depots • Pragmatic registration and activation • Use of centralised pharmacies to serve multiple sites |
Data and sample collection during a pandemic | • Reducing reporting burden through the use of protocol specified exempt events • Attempting to balance safety reporting with burden on site staff • Phone visits for discharged patients • Use of contractors for post-discharge sample collection |
Regulatory approval and study implementation outside the U.S. | • Sharing of regulators responses across the network • Use of a master protocol design with all new agent specific changes in an appendix • Mechanism to allow communication between relevant agencies in different countries |